ORCHID PHARMA
|
The Current P/E Ratio of ORCHID PHARMA is 44.26.
Share Price | ₹708.9 | Sep 16,2025 |
Market Cap | ₹3,594.1 Cr | |
Earnings-TTM | ₹81.2 Cr | TTM-Consolidated Results |
Price/Earnings | 44.26x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ORCHID PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹3,594.1 Cr] as on Sep 16,2025
(/) Earnings [ ₹81.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 44.26x ]
Thus, for ORCHID PHARMA , the investors are currently willing to pay 44.26 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ORCHID PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ORCHID PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of ORCHID PHARMA
PE Ratio Performance Analysis for ORCHID PHARMA
- ORCHID PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 26.19x.
- ORCHID PHARMA 's operated at median p/e ratio of 33.87x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ORCHID PHARMA 's p/e ratio peaked in Mar2024 at 57.52x.
- ORCHID PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does ORCHID PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ORCHID PHARMA | 81.20 | 44.26 | 3,594.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.12 | 386,497.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 70.16 | 161,787.0 |
CIPLA LTD | 5,406.81 | 23.28 | 125,870.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 59.74 | 119,591.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 19.10 | 109,380.0 |
MANKIND PHARMA LTD | 1,905.51 | 55.65 | 106,044.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 22.46 | 104,145.0 |
LUPIN LTD | 3,722.18 | 25.17 | 93,694.0 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.56 | 63,420.6 |
ABBOTT INDIA LTD | 1,452.29 | 45.31 | 65,799.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ORCHID PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.56x |
Max industry PE | 70.16x |
Median industry PE | 37.12x |
Average industry PE | 38.25x |
You may also like the below Video Courses